Following its successful US launch and FDA clearance, Empatica is proud to announce that EpiMonitor, its pioneering epilepsy monitoring solution, is now a CE-certified device according to EU Medical Device Regulation 2017/745 and available in Europe. EpiMonitor is a game-changing, medical-grade wearable and app combination that revolutionizes epilepsy care, providing seizure detection and alerting alongside continuous health monitoring capabilities also used in clinical research settings.

“We didn’t want to make just another health tracker, but to provide a lifeline for the millions of people living with epilepsy around the world.” Simone Tognetti, Empatica’s CTO & Co-founder

EpiMonitor comprises the sophisticated EmbracePlus watch and a companion smartphone app. EpiMonitor’s algorithm continuously analyzes user data, looking for patterns that may resemble a generalized tonic-clonic seizure, and sends automated alerts to caregivers with scientifically proven 98% accuracy. EpiMonitor also offers a detailed sleep, activity, and seizure diary, providing people with epilepsy and their doctors with important information to make empowered decisions on their health journey.

EpiMonitor is now available in Germany, France, Italy, Spain, Denmark, Sweden, Belgium, Luxembourg, Austria, Liechtenstein, Ireland, the Netherlands, Malta, and Finland. The EpiMonitor app is also available in all local languages for a seamless experience for its users.

Top IntentTech News: Acer Unveils Nitro GPUs with AMD & Intel Power

“EpiMonitor’s availability in Europe is a great milestone for the epilepsy community,” said Simone Tognetti, Empatica’s CTO & Co-founder. “Our goal is to continue bringing technology that improves lives to more people around the world. EpiMonitor is the world’s only non-invasive, medical-grade wearable for night and day epilepsy monitoring, and our rigorous engineering methods and quality processes guarantee unmatched safety and accuracy. With EpiMonitor, we have taken the best of our previous wearables and amplified it in a solution that uses our most innovative and powerful technology, alongside algorithms that provide detailed and meaningful health insights. We didn’t want to make just another health tracker, but to provide a lifeline for the millions of people living with epilepsy around the world.”

Key features of EpiMonitor include:

• Fully medical-grade technology consisting of a wearable and app
• Automatic generalized tonic-clonic seizure detection and alerts to caregivers (98% accuracy; low False Alarm Rate)
• Ability for users to send self-triggered alerts to caregivers
• Up to 7 days of battery life
• A user-friendly mobile app with a detailed, automated diary
• Daily sleep and activity tracking through Empatica’s algorithms
• Detailed reports that can be exported and shared with a doctor
• High accessibility with app translations in 8 languages
• Compatibility with iOS and Android smartphones

Top IntentTech News: Pocket Storage and Forum Launch Tech-Enabled Urban Storage

Empatica has been the market leader in providing the world’s only medical watches for people living with epilepsy for nearly a decade. Epilepsy affects 6 million people in Europe, with approximately 15% of those being children. Studies indicate that up to 40% of epilepsy cases are difficult to treat, and a third of people with epilepsy are refractory to current medications. Sudden Unexpected Death in Epilepsy (SUDEP) is the number one cause of epilepsy-related deaths in people with pharmacoresistant epilepsy. Most SUDEP deaths occur when a generalized tonic-clonic seizure occurs during sleep.

EpiMonitor can be purchased directly from the Empatica website. To learn more visit empatica.com/epimonitor.

Top IntentTech News: WeatherSTEM Advances Beach Safety Tools

To participate in our interviews, please write to our IntentTech Media Room at sudipto@intentamplify.com

Source – Businesswire